|
C12ORF11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.20390380892377E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.36689999506035E-08 |
| Normal-vs-Stage2 |
5.992300E-04 |
| Normal-vs-Stage3 |
5.53180000000264E-05 |
| Normal-vs-Stage4 |
6.38539999999743E-05 |
| Stage1-vs-Stage2 |
8.729200E-01 |
| Stage1-vs-Stage3 |
2.100200E-02 |
| Stage1-vs-Stage4 |
1.819860E-02 |
| Stage2-vs-Stage3 |
1.072200E-01 |
| Stage2-vs-Stage4 |
1.411930E-02 |
| Stage3-vs-Stage4 |
5.573000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.89089974181422E-10 |
| Normal-vs-AfricanAmerican |
1.72119999997111E-06 |
| Normal-vs-Asian |
7.599700E-02 |
| Caucasian-vs-AfricanAmerican |
6.147200E-01 |
| Caucasian-vs-Asian |
2.113200E-01 |
| AfricanAmerican-vs-Asian |
3.597600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.38720002151871E-09 |
| Normal-vs-Female |
3.91080001715949E-09 |
| Male-vs-Female |
5.100300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.238050E-04 |
| Normal-vs-Extreme_Weight |
4.21169999997861E-06 |
| Normal-vs-Obese |
9.93610000055156E-07 |
| Normal-vs-Extreme_Obese |
3.706000E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.579400E-01 |
| Normal_Weight-vs-Obese |
8.085000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.421000E-01 |
| Extreme_Weight-vs-Obese |
2.579000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.218600E-01 |
| Obese-vs-Extreme_Obese |
5.270000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.404500E-04 |
| Normal-vs-Age(41-60Yrs) |
6.73360256442379E-11 |
| Normal-vs-Age(61-80Yrs) |
1.93510000023878E-07 |
| Normal-vs-Age(81-100Yrs) |
6.941800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.347880E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.158860E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.721960E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.448000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.037400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.263800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.26560004090715E-09 |
| Normal-VS-Type2 PRCC |
2.40299999998417E-06 |
| Normal-VS-KIRP CIMP |
3.341800E-03 |
| Normal-VS-Unclassified PRCC |
1.801510E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.924600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.159400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.684000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.299800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.937800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.882840E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.19020000000026E-05 |
| Normal-vs-N1 |
1.5464699999912E-05 |
| Normal-vs-N2 |
1.394790E-01 |
| N0-vs-N1 |
1.858980E-03 |
| N0-vs-N2 |
2.287600E-01 |
| N1-vs-N2 |
7.223400E-01 |
|
|
